Ziqing Chen - Publications

Affiliations: 
Oncology and Pathology Karolinska Institute, Stockholm, Sweden 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Liu YN, Chen WY, Liu MK, Yeh HL, Chen WH, Jiang KC, Li HR, Chen ZQ, Wang WH, Abou-Kheir W, Wen YC. Immunosuppressive role of BDNF in therapy-induced neuroendocrine prostate cancer. Molecular Oncology. PMID 38381121 DOI: 10.1002/1878-0261.13614  0.343
2024 Neo SY, Oliveira MMS, Tong L, Chen Y, Chen Z, Cismas S, Burduli N, Malmerfelt A, Teo JKH, Lam KP, Alici E, Girnita L, Wagner AK, Westerberg LS, Lundqvist A. Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease. Journal of Experimental & Clinical Cancer Research : Cr. 43: 13. PMID 38191418 DOI: 10.1186/s13046-023-02917-5  0.521
2023 Tong L, Kremer V, Neo SY, Liu Y, Chen Y, Wagner AK, Yang Y, Chen Z, Seitz C, Tobin NP, Ligtenberg MA, Alici E, Chen X, Haglund F, Seliger B, et al. Renal cell carcinoma escapes NK cell-mediated immune surveillance through the downregulation of DNAM-1. Cancer Communications (London, England). PMID 37314951 DOI: 10.1002/cac2.12446  0.578
2023 Chen Z, Tong L, Neo SY, Li S, Gao J, Schlisio S, Lundqvist A. CD25 NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression. Oncoimmunology. 12: 2175517. PMID 36970070 DOI: 10.1080/2162402X.2023.2175517  0.714
2022 Schwietzer YA, Susek KH, Chen Z, Alici E, Wagner AK. A tractable microscopy- and flow cytometry-based method to measure natural killer cell-mediated killing and infiltration of tumor spheroids. Methods in Cell Biology. 178: 43-61. PMID 37516528 DOI: 10.1016/bs.mcb.2022.07.011  0.503
2022 Neo SY, Jing X, Tong L, Tong D, Gao J, Chen Z, De Los Santos MC, Burduli N, De Souza Ferreira S, Wagner AK, Alici E, Rolny C, Cao Y, Lundqvist A. Tumor MHC class I expression alters cancer-associated myelopoiesis driven by host NK cells. Journal For Immunotherapy of Cancer. 10. PMID 36283735 DOI: 10.1136/jitc-2022-005308  0.676
2021 Wu J, Chen Z, Wickström SL, Gao J, He X, Jing X, Wu J, Du Q, Yang M, Chen Y, Zhang D, Yin X, Guo Z, Jensen L, Yang Y, et al. Interleukin-33 is a Novel Immunosuppressor that Protects Cancer Cells from TIL Killing by a Macrophage-Mediated Shedding Mechanism. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2101029. PMID 34486239 DOI: 10.1002/advs.202101029  0.67
2021 Chen Z, Yang Y, Neo SY, Shi H, Chen Y, Wagner AK, Larsson K, Tong L, Jakobsson PJ, Alici E, Wu J, Cao Y, Wang K, Liu LL, Mao Y, et al. Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25 /CD54 NK cells. Embo Reports. e51329. PMID 33480074 DOI: 10.15252/embr.202051329  0.685
2020 Yang Y, Neo SY, Chen Z, Cui W, Chen Y, Guo M, Wang Y, Xu H, Kurzay A, Alici E, Holmgren L, Haglund F, Wang K, Lundqvist A. Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells. The Journal of Clinical Investigation. PMID 32673292 DOI: 10.1172/Jci137585  0.691
2019 Neo SY, Yang Y, Julien R, Ma R, Chen X, Chen Z, Tobin NP, Blake E, Seitz C, Thomas R, Wagner AK, Andersson J, de Boniface J, Bergh J, Murray S, et al. CD73 Immune Checkpoint Defines Regulatory NK-cells within the Tumor Microenvironment. The Journal of Clinical Investigation. PMID 31770109 DOI: 10.1172/Jci128895  0.71
2019 Chen Z, Yang Y, Liu LL, Lundqvist A. Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors. Cancers. 11. PMID 31340613 DOI: 10.3390/Cancers11071040  0.7
2008 Wu SH, Lu C, Dong L, Chen ZQ. Signal transduction involved in CTGF-induced production of chemokines in mesangial cells. Growth Factors (Chur, Switzerland). 26: 192-200. PMID 19378419 DOI: 10.1080/08977190802227828  0.317
Show low-probability matches.